Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA ‐ AF registry phase III

Documenti analoghi

• Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort
  di: Eva Soler‐Espejo, et al.
  Pubblicazione: (2025)
• Sex‐specific associations of body mass index and waist circumference loss with the risk of atrial fibrillation
  di: Hongmin Liu, et al.
  Pubblicazione: (2026)
• GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
  di: Tommaso Bucci, et al.
  Pubblicazione: (2025)
• Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease
  di: Weronika Stupalkowska, et al.
  Pubblicazione: (2025)
• SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation in type 2 diabetes mellitus
  di: Mark Luedde, et al.
  Pubblicazione: (2025)